Ackerman Capital Advisors, LLC Eli Lilly & CO Transaction History
Ackerman Capital Advisors, LLC
- $386 Million
- Q3 2024
A detailed history of Ackerman Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ackerman Capital Advisors, LLC holds 257 shares of LLY stock, worth $210,465. This represents 0.06% of its overall portfolio holdings.
Number of Shares
257
Previous 257
-0.0%
Holding current value
$210,465
Previous $232,000
2.16%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
3,912Shares Held
765MCall Options Held
6.35MPut Options Held
7.96M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$79.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$60.5 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.9 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.1 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.7 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $778B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...